Skip to main content
Premium Trial:

Request an Annual Quote

Quidel: Joseph Wilkins

Quidel has expanded the size of its board of directors from nine to ten members and appointed Joseph Wilkins to the board.

Wilkins is a partner at healthcare consulting firm TRG Healthcare, a limited partner at privately-held venture capital fund Tech Council Ventures, and is an advisor with Touchdown Ventures, a privately held venture capital group. He previously served as senior vice president and chief transformation and innovation officer for Atlantic Health System, an integrated healthcare delivery system, and prior to that he held positions at Quest Diagnostics and Danaher subsidiary Beckman Coulter.

The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to qualitative interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.